Teva Announces Tentative Approval of Generic Maxalt(R) Tablets

redorbit.com     Apr 17, 2008            

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. ... Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Merck's migraine pain treatment... [read full story]                    

Full Coverage